Cathie Wood: portfolio of ARK Investment Management

Cathie Wood leads ARK Investment Management, which offers actively managed funds focused on technology and innovation.

Source: 13F filing with the US Securities and Exchange Commission dated Nov 7, 2018. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included.

You are looking at Q3 2018. Go to the latest filing (Q3 2026)

3.3B USDQ3 2018
Total value of stock positions
3.3B USD
Positions
202
Share of the ten largest
40.3%

The ten largest positions Q3 2018

  1. Tesla, Inc. 6.0%▲ +68.2%
  2. Intellia Therapeutics Inc 5.0%▲ +27.5%
  3. Stratasys Ltd 4.8%▲ +1.5%
  4. Invitae Corp 4.6%▲ +4.0%
  5. Baidu (ADR) 4.2%▲ +46.7%
  6. Twitter Inc 3.5%
  7. Tencent Holdings Ltd 3.4%▲ +143.0%
  8. Block, Inc. 3.1%▼ −24.5%
  9. Illumina, Inc. 3.0%▼ −18.6%
  10. Nvidia 2.7%▲ +2.3%
Total value of stock positions per quarter, Q4 2016 to Q3 2026 (peak 53.7B USD).
Choose a quarter (40 filings)

All positions Q3 2018

Positions Q3 2018 per 13F filing, 19 of 19
Symbol Weight Shares Reported value Change Held since
AMD Advanced Micro Devices 0.6% 640,180 19.8M USD new Q3 2018 1 quarter
Opera Ltd 0.2% 631,887 5.7M USD new Q3 2018 1 quarter
Rubius Therapeutics Inc 0.1% 188,268 4.5M USD new Q3 2018 1 quarter
GrubHub Inc 0.1% 25,845 3.6M USD new Q3 2018 1 quarter
YY Inc 0.1% 46,859 3.5M USD new Q3 2018 1 quarter
BeiGene Ltd 0.1% 20,207 3.5M USD new Q3 2018 1 quarter
NXPI NXP Semiconductors < 0.1% 34,038 2.9M USD new Q3 2018 1 quarter
Kratos Defense & Security Solu < 0.1% 74,101 1.1M USD new Q3 2018 1 quarter
Attunity Ltd < 0.1% 44,600 842.0K USD new Q3 2018 1 quarter
Sapiens International Corp NV < 0.1% 53,187 703.0K USD new Q3 2018 1 quarter
MDT Medtronic < 0.1% 6,588 648.0K USD new Q3 2018 1 quarter
Intec Pharma Ltd < 0.1% 107,761 609.0K USD new Q3 2018 1 quarter
Together Startup Network Ltd < 0.1% 285,181 513.0K USD new Q3 2018 1 quarter
Galmed Pharmaceuticals Ltd < 0.1% 35,846 487.0K USD new Q3 2018 1 quarter
Ebix Inc < 0.1% 1,862 147.0K USD new Q3 2018 1 quarter
Evonik Industries AG < 0.1% 1,642 59.0K USD new Q3 2018 1 quarter
MMM 3M < 0.1% 499 53.0K USD new Q3 2018 1 quarter
GMO internet Inc < 0.1% 800 14.0K USD new Q3 2018 1 quarter
Spark Therapeutics Inc < 0.1% 129 7.0K USD new Q3 2018 1 quarter

“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.

Breakdown by sector

  • Technology 11.3%
  • Consumer Discretionary 9.9%
  • Health Care 4.2%
  • Financials 3.6%
  • Communication Services 2.9%
  • Industrials 0.2%
  • not in our coverage 67.9%

Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.

How to read this page

  • Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
  • Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
  • Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.

All superinvestor portfolios Screener: stocks held by superinvestors

↑ ↓ select · Enter open · Esc close